Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh

University of Pennsylvania Hospital, Philadelphia

The Center for Cancer and Blood Disorders (RCCA MD LLC- Maryland Division), Bethesda

Greater Baltimore Cancer Center, Baltimore

St. Agnes Hospital Cancer Institute, Baltimore

Virginia Cancer Specialists, Arlington

Greenville Health System Cancer Institute, Greenville

Georgia Cancer Specialists affiliated with Northside Hospital Cancer Institute, Atlanta

Miami Cancer Institute at Baptist Health, Inc, Miami

West Cancer Center, Germantown

The Christ Hospital Hematology Oncology, Lindner Research Center, Cincinnati

University of Michigan Hospital and Health Systems, Ann Arbor

Health Partners Institute, Saint Louis Park

The University of Chicago Medicine, Chicago

St. Francis Cancer Center, Topeka

University Of Texas Southwestern Medical Center At Dallas, Dallas

University Of Colorado Cancer Center, Aurora

The Angeles Clinic and Research Institute, Los Angeles

UC San Diego Moores Cancer Center, La Jolla

US Davis Cancer Center, Sacramento

University of Connecticut Health Center Carole And Ray Neag Comprehensive Cancer Center, Farmington

Hackensack University Medical Center - John Theurer Cancer Center, Hackensack

Fox Chase Cancer Center, Philadelphia

Sarah Cannon Research Institute at Tennessee Oncology, Nashville